Related Experiment Video
Updated: Aug 17, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Cutaneous infection caused by Alternaria in patients receiving tacrolimus
M Pereiro1, Maria M Pereiro Ferreirós, G S De Hoog
1Department of Dermatology, Complejo Hospitalario Universitario, Faculty of Medicine, Santiago de Compostela, Spain. manuelpe@usc.es
Abstract:
Tacrolimus, an immunosuppressant used in organ transplant surgery, is inhibitory to some medically important fungi but also may obstruct azole monotherapy in the immunocompromised patient. We observed a case of cutaneous phaeohyphomycosis caused by Alternaria alternata in a liver transplant recipient who had been under tacrolimus immunosuppression for 6 months post-transplantation. At the onset of the infection, the patient presented with an increased whole-blood tacrolimus level. After a simple surgical excision the patient was discharged from the hospital without antifungal treatment but with an adjusted tacrolimus dosage. Literature review on fungal infections in patients receiving tacrolimus suggested these patients experience cutaneous and deep mould infections that are more frequent, severe and therapy-refractory than those seen in patients with other types of immunosuppression.
Insights
Tacrolimus, an immunosuppressant, can increase fungal infection risk in transplant patients. Managing tacrolimus levels is crucial for treating infections like Alternaria alternata cutaneous phaeohyphomycosis.
Area of Science:
- Mycology
- Immunology
- Transplantation
Background:
- Tacrolimus is a vital immunosuppressant in organ transplantation.
- It exhibits antifungal properties but can complicate azole therapy in immunocompromised individuals.
- Patients on tacrolimus may be at higher risk for fungal infections.
Observation:
- A liver transplant recipient on tacrolimus developed cutaneous phaeohyphomycosis.
- The infection was caused by the fungus Alternaria alternata.
- The patient presented with elevated whole-blood tacrolimus levels during the infection.
Findings:
- Surgical excision was effective for this cutaneous fungal infection.
- Antifungal treatment was not required post-surgery.
- Tacrolimus dosage adjustment was implemented.
- Literature suggests tacrolimus-treated patients face more frequent, severe, and refractory fungal infections.
Implications:
- Close monitoring of tacrolimus levels is essential in transplant patients.
- Fungal infections in tacrolimus recipients may require tailored management strategies.
- Understanding drug interactions and patient immune status is critical for successful outcomes.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Staphylococcal Skin Infections
Acne Infection
Cryptococcal Meningitis
